Metolazone
- Generic Name
- Metolazone
- Brand Names
- Mykrox, Zaroxolyn
- Drug Type
- Small Molecule
- Chemical Formula
- C16H16ClN3O3S
- CAS Number
- 17560-51-9
- Unique Ingredient Identifier
- TZ7V40X7VX
Overview
A quinazoline-sulfonamide that is considered a thiazide-like diuretic which is long-acting so useful in chronic renal failure. It also tends to lower blood pressure and increase potassium loss.
Background
A quinazoline-sulfonamide that is considered a thiazide-like diuretic which is long-acting so useful in chronic renal failure. It also tends to lower blood pressure and increase potassium loss.
Indication
用于治疗水肿及高血压。
Associated Conditions
- Edema
- Hypertension
- Mild Hypertension
- Moderate Hypertension
Clinical Trials
FDA Approved Products
METOLAZONE
Manufacturer:Advagen Pharma Limited
Route:ORAL
Strength:2.5 mg in 1 1
Approved: 2022/10/17
NDC:72888-052
METOLAZONE
Manufacturer:Alembic Pharmaceuticals Inc.
Route:ORAL
Strength:5 mg in 1 1
Approved: 2022/04/26
NDC:62332-533
Metolazone
Manufacturer:American Health Packaging
Route:ORAL
Strength:5 mg in 1 1
Approved: 2021/10/20
NDC:60687-635
Metolazone
Manufacturer:Major Pharmaceuticals
Route:ORAL
Strength:5 mg in 1 1
Approved: 2023/08/30
NDC:0904-7329
Metolazone
Manufacturer:Major Pharmaceuticals
Route:ORAL
Strength:2.5 mg in 1 1
Approved: 2023/08/30
NDC:0904-7328
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath